Tiotropium and the risk of death in COPD

New England Journal of Medicine

Volumn 370, Issue 5, 2014, Pages 481-482

  Verhamme, Katia M C ^a   Van Blijderveen, Nico ^a   Sturkenboom, Miriam C J M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

TIOTROPIUM BROMIDE;

CHRONIC KIDNEY DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE ASSOCIATION; DRUG FATALITY; DRUG SAFETY; HUMAN; INHALER; KIDNEY FAILURE; LETTER; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC);

EID: 84893028857     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1314411     Document Type: Letter

References (1)

1. Verhamme KM, Afonso A, Romio S, Stricker BC, Brusselle GG, Sturkenboom MC. Use of tiotropium Respimat Soft Mist Inhaler versus HandiHaler and mortality in patients with COPD. Eur Respir J 2013;42:606-15.